Literature DB >> 15893774

Ketone bodies affect the enzymatic activity of macrophage migration inhibitory factor.

János Garai1, Tamás Lóránd, Valéria Molnár.   

Abstract

Macrophage migration inhibitory factor (MIF), a long known proinflammatory cytokine exhibits perplexing enzymatic activities: tautomeric conversion of D-dopachrome and phenylpyruvate. Whether these catalytic activities bear functional relevance regarding MIF's multifaceted roles is under current scrutiny. Nevertheless, intense search has already started for pharmacological agents that target MIF's tautomerase activity. We have probed several antiinflammatory compounds against keto--enol (enolase) and enol--keto (ketonase) conversion of phenylpyruvate by MIF with spectrophotometry. We have identified acidic CH groups as markers of inhibitor potency toward MIF phenylpyruvate tautomerase. Among simple model molecules with strong acidic CH groups we found acetylacetone the best inhibitor particularly against the ketonase activity. Ketones of physiological importance - ketone bodies - also feature acidic CH groups and have been reported to exert certain anti-inflammatory effects. In this paper we report that ketone bodies inhibit preferentially the ketonase activity of MIF in vitro. Future studies should address whether such an interaction might operate in vivo and delineate its possible relevance concerning cytokine and non-cytokine roles of MIF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893774     DOI: 10.1016/j.lfs.2005.03.010

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Proteomic changes associated with diabetes in the BB-DP rat.

Authors:  D Thor Johnson; Robert A Harris; Stephanie French; Angel Aponte; Robert S Balaban
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-11-04       Impact factor: 4.310

2.  Beta-hydroxybutyrate abrogates formation of bovine neutrophil extracellular traps and bactericidal activity against mammary pathogenic Escherichia coli.

Authors:  Navit Grinberg; Sharon Elazar; Ilan Rosenshine; Nahum Y Shpigel
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

3.  Model-driven multi-omic data analysis elucidates metabolic immunomodulators of macrophage activation.

Authors:  Aarash Bordbar; Monica L Mo; Ernesto S Nakayasu; Alexandra C Schrimpe-Rutledge; Young-Mo Kim; Thomas O Metz; Marcus B Jones; Bryan C Frank; Richard D Smith; Scott N Peterson; Daniel R Hyduke; Joshua N Adkins; Bernhard O Palsson
Journal:  Mol Syst Biol       Date:  2012-06-26       Impact factor: 11.429

4.  Revealing the molecular relationship between type 2 diabetes and the metabolic changes induced by a very-low-carbohydrate low-fat ketogenic diet.

Authors:  Judith Farrés; Albert Pujol; Mireia Coma; Jose Luis Ruiz; Jordi Naval; José Manuel Mas; Agustí Molins; Joan Fondevila; Patrick Aloy
Journal:  Nutr Metab (Lond)       Date:  2010-12-09       Impact factor: 4.169

5.  Increased B3GALNT2 in hepatocellular carcinoma promotes macrophage recruitment via reducing acetoacetate secretion and elevating MIF activity.

Authors:  Tianxiao Yang; Yilin Wang; Wenjuan Dai; Xixi Zheng; Jing Wang; Shushu Song; Lan Fang; Jiangfan Zhou; Weicheng Wu; Jianxin Gu
Journal:  J Hematol Oncol       Date:  2018-04-04       Impact factor: 17.388

6.  Recombinant Mycobacterium smegmatis delivering a fusion protein of human macrophage migration inhibitory factor (MIF) and IL-7 exerts an anticancer effect by inducing an immune response against MIF in a tumor-bearing mouse model.

Authors:  Hyein Jeong; So-Young Lee; Hyejun Seo; Bum-Joon Kim
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.